Abstract
Efficacy and Safety of Tabalumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study (P3.397)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have